A Phase 1 open-label, proof-of-concept clinical trial of OTX-TIC in patients with glaucoma and ocular hypertension
Phase of Trial: Phase I
Latest Information Update: 03 May 2018
At a glance
- Drugs Travoprost (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Adverse reactions; Proof of concept
- 03 May 2018 According to an Ocular Therapeutix media release, the company today announced the treatment of the first patient in a Phase 1 trial.
- 03 May 2018 Status changed from planning to recruiting, according to an Ocular Therapeutix media release.
- 27 Apr 2018 According to an Ocular Therapeutix media release, company plans to initiate clinical trials in the second quarter of 2018.